Stimulation of Phospholipase A2 Activity in Bovine Rod Outer
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Inhibitory Effects of Plant Phenolic Compounds on Enzymatic and Cytotoxic Activities Induced by a Snake Venom Phospholipase A
295 VITAE, REVISTA DE LA FACULTAD DE QUÍMICA FARMACÉUTICA ISSN 0121-4004 / ISSNe 2145-2660. Volumen 18 número 3, año 2011. Universidad de Antioquia, Medellín, Colombia. págs. 295-304 INHIBITORY EFFECTS OF PLANT PHENOLIC COMPOUNDS ON ENZYMATIC AND CYTOTOXIC ACTIVITIES INDUCED BY A SNAKE VENOM PHOSPHOLIPASE A 2 EFECTOS INHIBITORIOS DE COMPUESTOS FENÓLICOS DE PLANTAS SOBRE LA ACTIVIDAD ENZIMÁTICA Y CITOTOXICA INDUCIDA POR UNA FOSFOLIPASA A 2 DE VENENO DE SERPIENTE Jaime A. PEREAÑEZ 1*, Vitelbina NÚÑEZ 1,2 , Arley C. PATIÑO 1, Mónica LONDOÑO 1, Juan C. QUINTANA 1 Received: 23 February 2010 Accepted: 25 April 2011 ABSTRACT Polyphenolic compounds have shown to inhibit toxic effects induced by snake venom proteins. In this work, we demonstrate that gallic acid, ferulic acid, caffeic acid, propylgallate and epigallocatechingallate inhibit the enzymatic activity of a phospholipase A 2 (PLA 2), using egg yolk as substrate. The IC50 values are between 0.38 – 3.93 mM. These polyphenolic compounds also inhibit the PLA 2 enzymatic activity when synthetic substrate is used. Furthermore, these compounds decreased the cyotoxic effect induced by a myotoxic PLA 2; specifically, epigallocatechin gallate exhibited the best inhibitory capacity with 90.92 ± 0.82%, while ferulic acid showed the lowest inhibitory activity with 30.96 ± 1.42%. Molecular docking studies were performed in order to determine the possible modes of action of phenolic compounds. All polyphenols showed hydrogen bonds with an active site of enzyme; moreover, epigallocatechingallate presented the strongest binding compared with the other compounds. Additionally, a preliminary structure-activity relationship analysis showed a correlation between the IC50 and the topological polar surface area of each compound (p = 0.0491, r = -0.8079 (-0.9878 to -0.2593)), which indicates the surface area required for each molecule to bind with the majority of the enzyme. -
Lipolytic Enzymes
Proc. Natl. Acad. Sci. USA Vol. 92, pp. 3308-3312, April 1995 Biochemistry Interfacial activation-based molecular bioimprinting of lipolytic enzymes (lipases/phospholipase A2/nonaqueous media) ISMAEL MINGARRO, CONCEPCION ABAD, AND LORENZO BRACo* Departament de Bioquimica i Biologia Molecular, Facultat de Ciencies Biologiques, Universitat de Valencia, E-46100 Burjassot, Valencia, Spain Communicated by William P. Jencks, Brandeis University, Waltham, MA, October 19, 1995 (received for review June 28, 1994) ABSTRACT Interfacial activation-based molecular (bio)- ported yet, which contrasts with the extraordinary profusion imprinting (IAMI) has been developed to rationally improve during the last few years of nonaqueous studies of lipases. the performance of lipolytic enzymes in nonaqueous environ- Catalysis by lipolytic enzymes is characterized by the so-called ments. The strategy combinedly exploits (i) the known dra- interfacial activation (13), manifested as a pronounced activity matic enhancement of the protein conformational rigidity in increase upon substrate aggregation [i.e., over the substrate a water-restricted milieu and (ii) the reported conformational critical micelle concentration (cmc)]. It has long been pro- changes associated with the activation of these enzymes at posed that this activation should involve some discrete con- lipid-water interfaces, which basically involves an increased formational changes of the soluble enzyme in fixing itself at the substrate accessibility to the active site and/or an induction substrate surface (14). Recent evidence derived mainly from of a more competent catalytic machinery. Six model enzymes x-ray crystallographic studies in the case of triglyceride lipases have been assayed in several model reactions in nonaqueous (for review, see, for example, refs. -
Phosphodiesterase (PDE)
Phosphodiesterase (PDE) Phosphodiesterase (PDE) is any enzyme that breaks a phosphodiester bond. Usually, people speaking of phosphodiesterase are referring to cyclic nucleotide phosphodiesterases, which have great clinical significance and are described below. However, there are many other families of phosphodiesterases, including phospholipases C and D, autotaxin, sphingomyelin phosphodiesterase, DNases, RNases, and restriction endonucleases, as well as numerous less-well-characterized small-molecule phosphodiesterases. The cyclic nucleotide phosphodiesterases comprise a group of enzymes that degrade the phosphodiester bond in the second messenger molecules cAMP and cGMP. They regulate the localization, duration, and amplitude of cyclic nucleotide signaling within subcellular domains. PDEs are therefore important regulators ofsignal transduction mediated by these second messenger molecules. www.MedChemExpress.com 1 Phosphodiesterase (PDE) Inhibitors, Activators & Modulators (+)-Medioresinol Di-O-β-D-glucopyranoside (R)-(-)-Rolipram Cat. No.: HY-N8209 ((R)-Rolipram; (-)-Rolipram) Cat. No.: HY-16900A (+)-Medioresinol Di-O-β-D-glucopyranoside is a (R)-(-)-Rolipram is the R-enantiomer of Rolipram. lignan glucoside with strong inhibitory activity Rolipram is a selective inhibitor of of 3', 5'-cyclic monophosphate (cyclic AMP) phosphodiesterases PDE4 with IC50 of 3 nM, 130 nM phosphodiesterase. and 240 nM for PDE4A, PDE4B, and PDE4D, respectively. Purity: >98% Purity: 99.91% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 1 mg, 5 mg Size: 10 mM × 1 mL, 10 mg, 50 mg (R)-DNMDP (S)-(+)-Rolipram Cat. No.: HY-122751 ((+)-Rolipram; (S)-Rolipram) Cat. No.: HY-B0392 (R)-DNMDP is a potent and selective cancer cell (S)-(+)-Rolipram ((+)-Rolipram) is a cyclic cytotoxic agent. (R)-DNMDP, the R-form of DNMDP, AMP(cAMP)-specific phosphodiesterase (PDE) binds PDE3A directly. -
Cutinases from Mycobacterium Tuberculosis
Identification of Residues Involved in Substrate Specificity and Cytotoxicity of Two Closely Related Cutinases from Mycobacterium tuberculosis Luc Dedieu, Carole Serveau-Avesque, Ste´phane Canaan* CNRS - Aix-Marseille Universite´ - Enzymologie Interfaciale et Physiologie de la Lipolyse - UMR 7282, Marseille, France Abstract The enzymes belonging to the cutinase family are serine enzymes active on a large panel of substrates such as cutin, triacylglycerols, and phospholipids. In the M. tuberculosis H37Rv genome, seven genes coding for cutinase-like proteins have been identified with strong immunogenic properties suggesting a potential role as vaccine candidates. Two of these enzymes which are secreted and highly homologous, possess distinct substrates specificities. Cfp21 is a lipase and Cut4 is a phospholipase A2, which has cytotoxic effects on macrophages. Structural overlay of their three-dimensional models allowed us to identify three areas involved in the substrate binding process and to shed light on this substrate specificity. By site-directed mutagenesis, residues present in these Cfp21 areas were replaced by residues occurring in Cut4 at the same location. Three mutants acquired phospholipase A1 and A2 activities and the lipase activities of two mutants were 3 and 15 fold greater than the Cfp21 wild type enzyme. In addition, contrary to mutants with enhanced lipase activity, mutants that acquired phospholipase B activities induced macrophage lysis as efficiently as Cut4 which emphasizes the relationship between apparent phospholipase A2 activity and cytotoxicity. Modification of areas involved in substrate specificity, generate recombinant enzymes with higher activity, which may be more immunogenic than the wild type enzymes and could therefore constitute promising candidates for antituberculous vaccine production. -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase -
Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: a Canonical Pathway
Lipid related genes altered in NASH connect inflammation in liver pathogenesis progression to HCC: a canonical pathway Christophe Desterke1, Franck Chiappini2* 1 Inserm, U935, Villejuif, F-94800, France 2 Cell Growth and Tissue Repair (CRRET) Laboratory, Université Paris-Est Créteil (UPEC), EA 4397 / ERL CNRS 9215, F-94010, Créteil, France. Corresponding author: *Franck Chiappini. Laboratoire du CRRET (Croissance, Réparation et Régénération Tissulaires), Université Paris-Est Créteil, 61 avenue du Général de Gaulle F- 94010, Créteil Cedex, Val de Marne, France. Email address: [email protected]; Tel: +33(0)145177080; Fax: +33(0)145171816 Supplementary Information Supplementary Datasets Table S1: Text-mining list of genes associated in PubMed literature with lipid related keywords. Supplementary Datasets Table S2: Expression fold change of lipid related genes found differentially expressed between NASH and healthy obese liver samples. Supplementary Datasets Table S3: Liver as principal filter for prioritization of lipid related genes found differentially expressed in NASH. Supplementary Datasets Table S4: Gene prioritization secondary filters (immunological, inflammation, liver pathogenesis progression) table found with lipid related genes differentially expressed in NASH. Supplementary Datasets Table S5: Identification of protein partners of YWHAZ gene using InnateDB database. Supplementary Datasets Table S1: Text-mining list of genes associated in PubMed literature with lipid related keywords. Ranking of "lipidic" textmining Gene symbol -
Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in -
SERUM PARAOXONASE ACTIVITY in RENAL TRANSPLANT RECIPIENTS Saritha Gadicherla1, Suma M
Jebmh.com Original Research Article SERUM PARAOXONASE ACTIVITY IN RENAL TRANSPLANT RECIPIENTS Saritha Gadicherla1, Suma M. N2, Parveen Doddamani3 1Associate Professor, Department of Biochemistry, Sambhram Institute of Medical Sciences and Research, KGF, Karnataka, India. 2Professor, Department of Biochemistry, JSS Medical College, Mysuru, Karnataka, India. 3Consultant Biochemist, Department of Clinical Biochemistry, JSS Hospital, Mysuru, Karnataka, India. ABSTRACT BACKGROUND Serum paraoxonase is an enzyme synthesised in the liver. It is known to prevent atherosclerosis by inhibiting oxidation of low- density lipoprotein. Renal transplant recipients have increased tendency for developing atherosclerosis and cardiovascular disease. Reduced activity of serum paraoxonase contributes to accelerated atherosclerosis and increased cardiovascular complications in these patients. The aim of this study was to estimate serum paraoxonase activity in renal transplant recipients and compare it with healthy controls. MATERIALS AND METHODS 30 renal transplant recipients and 30 age and sex matched healthy controls were taken for the study. Serum paraoxonase activity, blood urea, serum creatinine and uric acid were estimated in these groups. The serum paraoxonase activity was correlated with urea, creatinine and uric acid levels. RESULTS Serum paraoxonase activity was reduced in renal transplant recipients compared to healthy controls. There was a negative correlation between paraoxonase activity and the levels of urea, creatinine and uric acid levels. CONCLUSION In this study, the paraoxonase activity was reduced in renal transplant recipients compared to controls. The increased cardiovascular disease in these patients could be due to reduced paraoxonase activity. KEYWORDS Paraoxonase, Renal Transplant Recipients, Atherosclerosis, Oxidised Low-Density Lipoprotein. HOW TO CITE THIS ARTICLE: Gadicherla S, Suma MN, Doddamani P. Serum paraoxonase activity in renal transplant recipients. -
Liver Cirrhosis Induces Renal and Liver Phospholipase A2 Activity in Rats Bannikuppe S
Liver Cirrhosis Induces Renal and Liver Phospholipase A2 Activity in Rats Bannikuppe S. Vishwanath,* Felix J. Frey,* Geneviève Escher,* Jürg Reichen,‡ and Brigitte M. Frey* *Division of Nephrology, Department of Medicine, and ‡Department of Clinical Pharmacology, University of Berne, 3010 Berne, Switzerland Abstract creased plasma volume (1–4). Besides arteriolar vasodilation and arteriovenous shunting, these patients exhibit a dimin- Maintenance of renal function in liver cirrhosis requires in- ished sensitivity to pressor hormones and impaired hypoxic creased synthesis of arachidonic acid derived prostaglandin vasoconstriction (5–7). Eventually liver failure causes extrahe- metabolites. Arachidonate metabolites have been reported patic organ dysfuntion such as hepatorenal or hepatopulmo- to be involved in modulation of liver damage. The purpose nary syndrome (8–10). These changes resemble those seen in of the present study was to establish whether the first en- patients or animals with septicemia (11–14). zyme of the prostaglandin cascade synthesis, the phospholi- Changes in arachidonic acid derived prostaglandins have pase A2(PLA2) is altered in liver cirrhosis induced by bile been linked to hemodynamic alterations in cirrhotic disease duct excision. the mRNA of PLA2(group I and II) and an- states (11, 15–19). Renal perfusion and glomerular filtration are nexin-I a presumptive inhibitor of PLA2 enzyme was mea- only maintained through the vasodilatory effect of prostaglan- sured by PCR using glyceraldehyde 3-phosphate dehydro- dins. Inhibition of the cyclooxygenase enzyme results in a re- genase (GAPDH) as an internal standard. The mean duction of the effective renal plasma flow and sodium retention mRNA ratio of group II PLA2/GAPDH was increased in (20, 21) and administration of exogenous prostaglandin E de- liver tissue by 126% (P , 0.001) and in kidney tissue by rivatives enhance renal function of patients with cirrhosis (22). -
Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA
G C A T T A C G G C A T genes Review Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA Suguru Morimoto 1, Masataka Tsuda 1, Heeyoun Bunch 2 , Hiroyuki Sasanuma 1, Caroline Austin 3 and Shunichi Takeda 1,* 1 Department of Radiation Genetics, Graduate School of Medicine, Kyoto University, Yoshida Konoe, Sakyo-ku, Kyoto 606-8501, Japan; [email protected] (S.M.); [email protected] (M.T.); [email protected] (H.S.) 2 Department of Applied Biosciences, College of Agriculture and Life Sciences, Kyungpook National University, Daegu 41566, Korea; [email protected] 3 The Institute for Cell and Molecular Biosciences, the Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; [email protected] * Correspondence: [email protected]; Tel.: +81-(075)-753-4411 Received: 30 September 2019; Accepted: 26 October 2019; Published: 30 October 2019 Abstract: Type II DNA topoisomerase enzymes (TOP2) catalyze topological changes by strand passage reactions. They involve passing one intact double stranded DNA duplex through a transient enzyme-bridged break in another (gated helix) followed by ligation of the break by TOP2. A TOP2 poison, etoposide blocks TOP2 catalysis at the ligation step of the enzyme-bridged break, increasing the number of stable TOP2 cleavage complexes (TOP2ccs). Remarkably, such pathological TOP2ccs are formed during the normal cell cycle as well as in postmitotic cells. Thus, this ‘abortive catalysis’ can be a major source of spontaneously arising DNA double-strand breaks (DSBs). -
Potent Lipolytic Activity of Lactoferrin in Mature Adipocytes
Biosci. Biotechnol. Biochem., 77 (3), 566–571, 2013 Potent Lipolytic Activity of Lactoferrin in Mature Adipocytes y Tomoji ONO,1;2; Chikako FUJISAKI,1 Yasuharu ISHIHARA,1 Keiko IKOMA,1;2 Satoru MORISHITA,1;3 Michiaki MURAKOSHI,1;4 Keikichi SUGIYAMA,1;5 Hisanori KATO,3 Kazuo MIYASHITA,6 Toshihide YOSHIDA,4;7 and Hoyoku NISHINO4;5 1Research and Development Headquarters, Lion Corporation, 100 Tajima, Odawara, Kanagawa 256-0811, Japan 2Department of Supramolecular Biology, Graduate School of Nanobioscience, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan 3Food for Life, Organization for Interdisciplinary Research Projects, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan 4Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyou-ku, Kyoto 602-8566, Japan 5Research Organization of Science and Engineering, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga 525-8577, Japan 6Department of Marine Bioresources Chemistry, Faculty of Fisheries Sciences, Hokkaido University, 3-1-1 Minatocho, Hakodate, Hokkaido 041-8611, Japan 7Kyoto City Hospital, 1-2 Higashi-takada-cho, Mibu, Nakagyou-ku, Kyoto 604-8845, Japan Received October 22, 2012; Accepted November 26, 2012; Online Publication, March 7, 2013 [doi:10.1271/bbb.120817] Lactoferrin (LF) is a multifunctional glycoprotein resistance, high blood pressure, and dyslipidemia. To found in mammalian milk. We have shown in a previous prevent progression of metabolic syndrome, lifestyle clinical study that enteric-coated bovine LF tablets habits must be improved to achieve a balance between decreased visceral fat accumulation. To address the energy intake and consumption. In addition, the use of underlying mechanism, we conducted in vitro studies specific food factors as helpful supplements is attracting and revealed the anti-adipogenic action of LF in pre- increasing attention. -
Phospholipase and Lysophospholipase Activities of Goat Spermatozoa in Transit from the Caput to the Cauda Epididymidis S
Phospholipase and lysophospholipase activities of goat spermatozoa in transit from the caput to the cauda epididymidis S. K. Atreja and S. R. Anand National Dairy Research Institute, Karnal-132001, India Summary. Phospholipase and lysophospholipase activities were assayed in goat epididymal spermatozoa. Lysophospholipase was 10 times more active than phospholipase, and both enzymes decreased in activity substantially in the transit of spermatozoa from the caput to the cauda epididymidis. A comparative study revealed that phosphatidyl-ethanolamine, -choline and -inositol and phosphatidic acid were hydrolysed by goat sperm phospholipase. Hydrolysis of phosphatidylethanol- amine/phosphatidylcholine revealed the end products to be glycerophosphoethanol- amine/choline but neither diglycerides nor lysophosphatidylethanolamine/lysophos- phatidylcholine were detected. Introduction Glycolysable substrates are not available to mammalian spermatozoa in the epididymis. Therefore, for 'ripening or maturation' in the epididymis, spermatozoa must derive energy by the oxidation of other substrates, such as phospholipids which decrease markedly during the transit of spermatozoa from the caput to cauda region (Mann & Lutwak-Mann, 1981). There are, however, no studies of the phospholipases that release fatty acids from the phospholipids in the epididymis, although Scott & Dawson (1968) have described the hydrolysis of ethanolamine phosphoglycerides and phosphatidylinositol by ejaculated spermatozoa of rams and bulls. In this study, we have examined the phospholipase and lysophospholipase activities of spermatozoa in different regions of the goat epididymis. Materials and Methods Chemicals. Phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, phosphatidic acid, glycerophospho-ethanolamine/-choline, snake venom (Crotalus atrox), PPO, POPOP and methyl esters of fatty acids were obtained from Sigma Chemicals Co., St Louis, MO, U.S.A. Lysophosphatidylcholine and lysophosphatidylethanolamine were purchased from Patel Chest Institute, New Delhi, India.